Portal de investigação
Cardiovascular Prevention in Obese Patients Without Diabetes: Risk-based Strategies Are Needed
Autores da FMUP
Unidades de investigação
Abstract
[No abstract available]
Dados da publicação
- ISSN/ISSNe:
- 1071-9164, 1532-8414
- Tipo:
- Editorial Material
- Páginas:
- 418-420
- Link para outro recurso:
- www.scopus.com
Journal of Cardiac Failure Churchill Livingstone
Citações Recebidas na Web of Science: 1
Citações Recebidas na Scopus: 1
Documentos
- Não há documentos
Filiações
Keywords
- Cardiovascular Diseases; Diabetes Mellitus, Type 2; Heart Failure; Humans; Obesity; Risk Factors; placebo; semaglutide; absolute risk reduction; Article; cardiovascular disease; cardiovascular mortality; cardiovascular risk factor; cerebrovascular accident; control strategy; controlled clinical trial (topic); drug efficacy; drug safety; event free survival; gastrointestinal symptom; heart failure; heart failure free survival; heart infarction; heart protection; human; mean survival time; numbers needed to treat; obese patient; obesity; personalized medicine; prognosis; restricted mean survival time; risk management; risk reduction; survival; cardiovascular disease; complication; heart failure; non insulin dependent diabetes mellitus; obesity; risk factor
Proyectos asociados
Dapagliflozin, Spironolactone or Both for HFpEF (SOGALDI-PEF) - NCT05676684
Investigador Principal: João Pedro Melo Marques Pinho Ferreira
Ensaio Clínico Académico (SOGALDI-PEF) . AstraZeneca . 2022
The Canadian CABG or PCI in Patients with Ischemic Cardiomyopathy Trial (STICH 3C) - NCT05427370
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Ensaio Clínico Académico (STICH 3C) . Cornell University . 2023
Initiation of ARNi and SGLT2i in Patients With HFrEF: Randomized Open-label Trial (INITIATE-HFrEF) -NCT05989503
Investigador Principal: João Pedro Melo Marques Pinho Ferreira
Ensaio Clínico Académico (INITIATE-HFrEF) . Novartis . 2023
Predictors of readmission and mortality in patients with decompensated heart failure according to glycaemic status
Investigador Principal: João Sérgio de Lima Soares Neves
Estudo Clínico Académico (Glycaemic status) . 2023
Association of Glycemic Variability and Time in Range with Lipid Profile in Type 1 Diabetes
Investigador Principal: João Sérgio de Lima Soares Neves
Estudo Clínico Académico (Glycemic Variability) . 2023
Time in Range and Complications of Diabetes: a Cross-Sectional Analysis of patients with Type 1 Diabetes
Investigador Principal: João Sérgio de Lima Soares Neves
Estudo Clínico Académico (Type 1 Diabetes) . 2023
Evaluation of thyroid function in patients hospitalized for acute heart failure
Investigador Principal: João Sérgio de Lima Soares Neves
Estudo Clínico Académico (Heart failure) . 2021
Predictors Of The Effectiveness Of Insulin Pumps In Patiens With Type 1 Diabetes Mellitus
Investigador Principal: João Sérgio de Lima Soares Neves
Estudo Clínico Académico . 2021
Impacto da pandemia COVID-19 no controlo metabólico de doentes com Diabetes Mellitus Tipo 1
Investigador Principal: João Sérgio de Lima Soares Neves
Estudo Clínico Académico . 2022
Influence of Diabetes on Response to Ultrasound Guided Hydrodistension Treatment of Adhesive Capsulitis: a Retrospective Study
Investigador Principal: João Sérgio de Lima Soares Neves
Estudo Clínico Académico (Hydrodistension ) . 2022
Influence of Cystic Fibrosis-Related Diabetes on the Severity of Cystic Fibrosis Phenotype
Investigador Principal: João Sérgio de Lima Soares Neves
Estudo Clínico Académico . 2022
Citar a publicação
Ferreir JP,Neves JS,Saraiva F. Cardiovascular Prevention in Obese Patients Without Diabetes: Risk-based Strategies Are Needed. J. Card. Fail. 2024. 30(2):p. 418-420. IF:6,000. (1).
